Kenyan Health Patient Information Leaflet
Therapeutic agent (verify pharmacological class)
Long-term (up to 5 years) prevention of pregnancy Clinical selection for Levonorgestrel Implant should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
One capsule is implanted once after every 5 years. The capsules should be removed by the end of the 5th year.
Vaginal fungal infection; hypersensitiv-ity to the components of the formulation; headache; nausea; breast tenderness; mood, affect and anxiety disorders; migraine; dizziness; abdominal pain; vomiting; diarrhea; abdominal distension; weight increase; edema; dysmenorrhea; vaginal bleeding; menstrual bleeding.
Store as labelled. Keep out of reach of children.